We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As the name suggests, the fresh and citrusy fragrance perfectly captures the Italian riviera and everything that comes with it. As well as notes of lemon and bergamot, a top note of Tunisian ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) on January 27 and set a price target of $73.00. The company’s shares closed yesterday at ...

In this article, we are going to take a look at where Akero Therapeutics Inc. (NASDAQ:AKRO) stands against the other stocks. Wall Street ended the first trading day of the week on a mixed note ...

On Monday, Akero Therapeutics, Inc. (NASDAQ:AKRO) released preliminary topline week 96 results from SYMMETRY Phase 2b study evaluating the efficacy and safety of its lead product candidate ...

(RTTNews) - Akero Therapeutics, Inc. (AKRO), Monday, announced encouraging preliminary topline Week-96 results from a phase IIb trial of its investigational drug Efruxifermin in patients with ...

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

$AKRO insiders have traded $AKRO stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.